Filter
822
Text search:
drug
shortage
Featured
Recommendations
65
New Publications
285
Language
Document type
No document type
523
Studies & Reports
132
Guidelines
76
Strategic & Response Plan
36
Manuals
30
Training Material
12
Situation Updates
7
Fact sheets
3
Infographics
2
Brochures
1
Countries / Regions
India
42
Ethiopia
36
Kenya
32
Uganda
29
Liberia
28
Malawi
27
Sierra Leone
26
Tanzania
24
South Africa
24
Western and Central Europe
24
Nigeria
23
Zambia
20
Bangladesh
20
Myanmar / Burma
20
Global
19
Namibia
16
Lesotho
13
Ghana
12
Zimbabwe
12
Nepal
11
Botswana
11
Asia
11
Eastern Europe
11
Syria
10
Africa
10
Cambodia
9
Mozambique
9
Latin America and the Carribbean
9
Rwanda
8
Ukraine
7
South–East Asia Region
7
Burkina Faso
6
Philippines
6
Senegal
5
Haiti
5
South Sudan
5
Guinea
4
Germany
4
Indonesia
4
Venezuela
4
Vietnam
4
Cameroon
3
Pakistan
3
Thailand
3
Benin
3
North Macedonia
3
East and Southern Africa
3
West and Central Africa
3
Laos
3
Russia
3
Moldova
3
Congo, Democratic Republic of
2
Jordan
2
Afghanistan
2
Lebanon
2
Eswatini/ Swaziland
2
Brazil
2
Colombia
2
Yemen
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Palestine
2
Albania
2
Tajikistan
2
USA
1
Turkey
1
China
1
Papua New Guinea
1
Central African Republic
1
Argentina
1
Peru
1
Hungary
1
Bolivia
1
Libya
1
Madagascar
1
Mexico
1
Sri Lanka
1
Chile
1
Poland
1
Italy
1
Timor Leste/ East Timor
1
Bulgaria
1
Estonia
1
Lithuania
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
432
Clinical Guidelines
51
Public Health
31
Key Resources
26
Women & Child Health
24
Capacity Building
10
Pharmacy & Technologies
5
Toolboxes
TB
58
Mental Health
56
COVID-19
49
HIV
47
AMR
31
NTDs
22
Caregiver
19
Conflict
17
Pharmacy
17
NCDs
16
Malaria
14
Ebola & Marburg
13
Disability
11
Natural Hazards
9
Planetary Health
9
Rapid Response
8
Global Health Education
8
Cholera
6
Refugee
6
Health Financing Toolbox
6
2.0 Rapid Response
4
Polio
3
Specific Hazards
2
Social Ethics
2
Zika
1
Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug
...
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati
...
A summary of the national drug situation
Many low-resource settings have a shortage of physicians and health workers. (1) In order to provide patient-centred continuous care more effectively, primary care systems can include team-based care strategies in their clinic workflows and protocol
...
UN GUIDE POUR L’APPROVISIONNEMENTEN MÉDICAMENTS/ A guide for drug supply
Bochure in English and French
Antimicrobial resistance is a global threat as it is present in all parts of the world and it means that there is a shortage of effective antibiotics to treat simple infections and diseases, also statistics reveal that because of antimicrobial resis
...
The Infection Prevention and Control (IPC) Legal Framework comes before the Specialized Technical Committee on Health and Drug Control for adoption and endorsement. The IPC Legal Framework is designed to guide Member States in the review and strengt
...
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resis
...
N95 or equivalent respirators are single-use personal protective equipment (PPE) designed for use by health workers that provide direct care to patients with diseases transmitted by aerosols or during aerosol generating procedures (AGP) for patients with acute respiratory disease, as is the case of
...
This guide helps pharmacists to understand their role in the hypertension program. From maintaining hypertensive drug stock, to drug dispensing, to recording and reporting, to awareness generation w
...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report
...
Tuberculosis treatment failure results in increased risk of morbidity, drug resistance, transmission and mortality. There are few data about tuberculosis treatment outcomes in Burkina Faso. The current study investigated the factors associated with
...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resis
...
The global increase of healthcare-associated infections (HAI) presents a growing concern in healthcare worldwide. According to the European Centre for Disease Prevention and Control (ECDC), the annual number of HAI exceeds 2.6million and produces the highest estimated amou
...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f
...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug
...
The National Strategic Plan on Malaria Prevention and Elimination Period 2021 – 2025 seeks to build on the previous national successes of the National Institute of Malariology, Parasitology, and Entomology (NIMPE) while addressing current challenges to reduce the overall burden of malaria in the S
...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G
...
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to
...
